|| Checking for direct PDF access through Ovid
In adults, continuous glucose monitoring used with pump-delivered insulin (PDI) or as part of an integrated, continuous monitor-in-pump delivered insulin (IPDI) system reduces glycated hemoglobin (HbA1C) 0.29 to 1.1 points more than self-monitoring of blood glucose with multiple daily injections of insulin (MDI). In young adults, continuous monitoring is no different from selfmonitoring for lowering HbA1C. In children, continuous monitoring with PDI or IPDI lowers HbA1C by 0.24 points more than self-monitoring with MDI at 3 months (SOR: C, meta-analysis of RCTs with disease-oriented evidence). Use of continuous monitoring to lower HbA1C is supported in adults and may be helpful in children (SOR: C, expert opinion).